Henry E. Schea
President bij Genopoietic SA
Actieve functies van Henry E. Schea
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Genopoietic SA
 Genopoietic SA BiotechnologyHealth Technology Part of AVAX Technologies, Inc., Genopoietic SA is a French company that researches and develops cell and gene therapy for cancer, autoimmune diseases, and orthopedics. The company is based in Paris, France. Genopoietic was acquired by AVAX Technologies, Inc. on August 24, 2000 for $198.62 million. | President | 21-10-2011 | - |
Loopbaan van Henry E. Schea
Eerdere bekende functies van Henry E. Schea
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AVAX TECHNOLOGIES, INC. | Algemeen Adviseur | 04-01-2010 | 01-04-2016 |
Opleiding van Henry E. Schea
| University of Massachusetts | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Frankrijk | 2 |
Operationeel
| General Counsel | 1 |
| President | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AVAX TECHNOLOGIES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Genopoietic SA
Genopoietic SA BiotechnologyHealth Technology Part of AVAX Technologies, Inc., Genopoietic SA is a French company that researches and develops cell and gene therapy for cancer, autoimmune diseases, and orthopedics. The company is based in Paris, France. Genopoietic was acquired by AVAX Technologies, Inc. on August 24, 2000 for $198.62 million. | Health Technology |
- Beurs
- Insiders
- Henry E. Schea
- Ervaring
